In its orthopedics product portfolio the company offers ALSAVIN Family, an innovative intra-articular injection to heal degenerative joint disease (osteoarthritis) that restricts movement and causes pain in joints.
ALSAVIN, ALSAVIN Supra and ALSAVIN One intra-articular injections, which are developed in 3 different concentrations according to the needs of the patients, contain sodium hyaluronate compatible with the human body. ALSAVIN 20 mg, ALSAVIN Supra 32 mg, ALSAVIN One 48 mg sodium hyaluronate structure can be administered to patients by medical professionals according to the needs of the patients.
ALSAVIN Family is obtained from �non-animal based bio-fermentation methods, which can be determined as High-Tech Recombinant DNA (RDNA) Biotechnology achieves pure material from plasmid. Long monotype HA chains produced by RDNA Biofermentation method are obtained from a microorganism capable of synthesizing high molecular weight HA (3.0 MDa).
Let’s block ads! (Why?)
New Application Ensures Route Coverage and Improves Driver Efficiency IRVINE, Calif., May 01, 2024 (GLOBE…
Reaffirms Full-Year 2024 Guidance; Achieves Commercial Production at Rochester CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (“Coeur” or…
DUBLIN--(BUSINESS WIRE)--The "Global Anti-Venom Market Report by Type, Animal Type, End User, Region and Company…
First quarter net income attributable to Rayonier of $1.4 million ($0.01 per share) on revenues…
LambdaTest Tunnel boosts its security and performance with SOCKS5 proxy and HTTP/2 support, enabling secure,…
WUHAN, China--(BUSINESS WIRE)--With the acceleration of globalization, China automobile industry is facing new opportunities for…